Determinants of radical prostatectomy in the prostate, lung, colorectal, ovarian (PLCO) cancer screening trial

被引：0
|
作者：
Miller, David C.
Church, Timothy R.
Hickey, Thomas
Greenlee, Robert T.
Lzmirlian, Grant
Mabie, Jerome
Riley, Thomas L.
Ragard, Lawrence
Prorok, Philip C.
Berg, Christine D.
Crawford, E. David
Andriole, Gerald L.
Grubb, Robert L.
机构：
来源：
JOURNAL OF UROLOGY | 2008年 / 179卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(08)60090-7
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [31] Impact of PSA screening on mortality - PLCO Project Team (Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial)
    Heidenreich, A.
    Nitschmann, S.
    [J]. INTERNIST, 2010, 51 (02): : 219 - 220
  • [32] Validation of an Algorithm for Classifying Interval Colorectal Cancer Occurrence: Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
    Pabby, Ajay
    Weissfeld, Joel L.
    Pinsky, Paul F.
    Hayes, Richard B.
    Schoen, Robert E.
    [J]. GASTROINTESTINAL ENDOSCOPY, 2006, 63 (05) : AB220 - AB220
  • [33] Dietary phytoestrogen intake and lung cancer risk: an analysis of the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial
    Wang, Qian
    Ru, Meng
    Zhang, Yaning
    Kurbanova, Tamara
    Boffetta, Paolo
    [J]. CARCINOGENESIS, 2021, 42 (10) : 1250 - 1259
  • [34] Cumulative false-positives (FP) in the prostate, lung, colorectal, ovarian (PLCO) cancer screening trial
    Miller, J. H.
    Kramer, B. S.
    Kreimer, A. R.
    Prorok, P. C.
    Xu, J.
    Baker, S. G.
    Fagerstrom, R.
    Berg, C. D.
    Gohagan, J. K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [35] Dietary fat intake and risk of pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Arem, Hannah E.
    Mayne, Susan T.
    Sampson, Joshua
    Risch, Harvey
    Stolzenberg-Solomon, Rachael Z.
    [J]. CANCER RESEARCH, 2013, 73 (08)
  • [36] Inflammatory potential of diet and risk of pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Zheng, Jiali
    Merchant, Anwar T.
    Wirth, Michael D.
    Zhang, Jiajia
    Antwi, Samuel O.
    Shoaibi, Azza
    Shivappa, Nitin
    Stolzenberg-Solomon, Rachael Z.
    Hebert, James R.
    Steck, Susan E.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (12) : 2461 - 2470
  • [37] The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: History, organization, and status
    Gohagan, JK
    Prorok, PC
    Hayes, RB
    Kramer, BS
    [J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 251S - 272S
  • [38] Dietary patterns predict mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort
    Tseng, Marilyn
    Graubard, Barry I.
    Ziegler, Regina
    [J]. FASEB JOURNAL, 2011, 25
  • [39] Recruitment strategies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: The first six years
    Simpson, NK
    Johnson, CC
    Ogden, SL
    Gamito, E
    Trocky, N
    McGuire, C
    Martin, J
    Barrow, S
    Lamerato, L
    Flickinger, LM
    Broski, KG
    Engelhard, D
    Hilke, C
    Bonk, J
    Gahagan, B
    Gren, LH
    Childs, J
    Lappe, K
    Fouad, M
    Thompson, J
    Sullivan, D
    [J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 356S - 378S
  • [40] Serum Vitamin D and Risk of Bladder Cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
    Mondul, Alison M.
    Weinstein, Stephanie J.
    Horst, Ronald L.
    Purdue, Mark
    Albanes, Demetrius
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (07) : 1222 - 1225
12345